EbookNetworking
🔍 Search Books
Home
›
Authors
›
Joseph Pickett
Books by Joseph Pickett
22 books
📄 Lite AMP version
Full site ›
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
FDA guidance on new OTC drug, supplement AE reporting law seen by September, audits to follow.: An article from: Inspection Monitor
Joseph Pickett
Thomson Gale
View Details ›
Wyeth hit with 54-item 483 for OOS results, faulty aseptic results, HVAC.(Human drugs): An article from: Validation Times
Joseph Pickett
Washington Information Source
View Details ›
FDA envisions slight drop in audits for biologics, drugs in FY '06; device inspections to stay even.: An article from: Inspection Monitor
Joseph Pickett
Washington Information Source
View Details ›
Sterility problems and OOS stability results trip up Sanofi Pasteur.(Biologics): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
12-item 483 for CI highlights examples of poor trial site oversight.(Clinical investigators): An article from: Bioresearch Monitoring Alert
Joseph Pickett
Washington Information Source
View Details ›
OOS results, media hold-time specifications, flawed validation reports net IDEC 10-item 483.(Biologics): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Biogen cited for cleaning/autoclave validation, faulty filter extractable studies.(Human drugs): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Validation flaws and lack of instrument calibration net 9-item 483.(Human/animal drugs): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
O'Farrell slapped with 13-item 483 for instrument calibration flaws; owner blasts agency.: An article from: Validation Times
Joseph Pickett
Washington Information Source
View Details ›
New guidance on inactives used in generics to be released.(Excipients): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
23-item 483 issued to Advanced Bionics for quality audits, process validation and risk analysis faults.(Medical devices): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Mammalian cell technology improving, expert notes; 1-4g/L realized now, 5-10g/L expected soon.(Biotech): An article from: Validation Times
Joseph Pickett
Washington Information Source
View Details ›
FDA GMP inspections tend to focus on the '6 P's', says Novartis QA representative.(Special Report: Surviving FDA GMP Inspections): An article from: Inspection Monitor
Joseph Pickett
Thomson Gale
View Details ›
Validity of some MDS Pharma studies questioned by agency; pending NDAs could be delayed.(Compliance/enforcement): An article from: BioResearch Compliance Report
Joseph Pickett
Thomson Gale
View Details ›
MDS Pharma Services slapped with 3-item 483 concerning contamination following bioequivalence audit.(CROs): An article from: Bioresearch Monitoring Alert
Joseph Pickett
Thomson Gale
View Details ›
Nine-item 483 for Positron for calibration and quality audit problems.(Medical devices): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Presence of particulate matter in vials top reason for product recalls, Pfizer executive reports at PDA conference.(Recalls): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Clinical trials must be registered if research is funded by pharma industry.(Registeries): An article from: BioResearch Compliance Report
Joseph Pickett
Thomson Gale
View Details ›
Andrx Pharma on receiving end of 9-item 483 for OOS, QC violations, control procedures.: An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
FDA gives pharma companies regulatory relief as they implement PAT.(Process analytical technology): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Big pharma to begin rollout of SAFE electronic sig system in 2007.(Electronic records): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
Part 11 rears its head in Draxis Pharma 3-item 483.(Human drugs): An article from: Validation Times
Joseph Pickett
Thomson Gale
View Details ›
